High-resolution spatial profiling identifies disease-specific molecular architecture in palmoplantar pustulosis
Preprint
Abstract
Palmoplantar pustulosis (PPP) and dyshidrotic eczema (DE) are chronic vesiculopustular dermatoses with overlapping clinical presentations but distinct underlying biology. Although comparative transcriptomic and proteomic analyses between PPP and DE have been reported, they remain limited in number and scope, with no comprehensive understanding of their distinct molecular signatures. Moreover, their molecular mechanisms remain unclear, and currently available therapeutic options are limited. To clarify disease-specific epidermal programs underlying vesicle formation, we conducted Visium HD spatial transcriptomic analysis of FFPE lesional skin samples obtained from patients with PPP and DE, followed by immunohistochemical validation against normal palmoplantar skin controls. Spatial clustering identified a keratinocyte subpopulation adjacent to vesicles that exhibited distinct transcriptional programs in the two diseases. In PPP, vesicle-associated keratinocytes demonstrated marked downregulation of aquaporin-3 (AQP3) and E-cadherin, together with strong, spatially localized activation of JAK-STAT3 signaling. Conversely, DE exhibited diffuse AQP3 expression and more homogeneous activation of JAK-STAT3 signaling throughout the epidermis. These results indicate that, although PPP and DE share inflammatory pathways, they differ substantially in their spatial molecular architecture. Reduced AQP3 expression and localized STAT3 activation may contribute to vesicle formation in PPP, supporting our previous hypothesis that implicates intraepidermal sweat leakage as a pathogenic mechanism in PPP. Abstract Figure:Keywords
Funding Information
- JSPS KAKENHI (23K07768)
- The Japanese Society for Psoriasis Research (UCB Research Grant Award 2025)
- Sun Pharma Co. Ltd (Research grant)
This publication has 29 references indexed in Scilit:
- Single-cell and spatial transcriptomics unveil myeloid–lymphoid cross talk and the dermal immune niche underlying palmoplantar pustulosisJournal of Allergy and Clinical Immunology, 2026
- Ethnic Differences of Palmoplantar Pustulosis: A Systematic ReviewAmerican Journal of Clinical Dermatology, 2025
- Upadacitinib Versus Acitretin for the Resolution of Pustules in Palmoplantar Pustulosis During Acute Phase: A Single-Center, Open-Label Prospective Cohort StudyAmerican Journal of Clinical Dermatology, 2025
- Palmoplantar Pustulosis as an Immune-Mediated Inflammatory Disease with a Possible Relevance of Th17 Cell Plasticity: A Narrative ReviewDermatology and Therapy, 2025
- Disease heterogeneity and molecular classification of inflammatory palmoplantar diseasesJournal of Allergy and Clinical Immunology, 2024
- Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding StudyDermatology and Therapy, 2023
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritisJAAD Case Reports, 2019
- Blockade of TNF receptor superfamily 1 (TNFR1)–dependent and TNFR1-independent cell death is crucial for normal epidermal differentiationJournal of Allergy and Clinical Immunology, 2019
- N-Acetylglutaminoyl-S-farnesyl-l-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytesArchives of Dermatological Research, 2016
- Tumor necrosis factor-α decreases aquaporin-3 expression in DJM-1 keratinocytesBiochemical and Biophysical Research Communications, 2009